/MMNFF
MMNFF Stock - MedMen Enterprises Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+9900.00%
+$0.00 (+9900.00%) • Feb 7
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.64
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MMNFF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.40
52W High$0.04
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $140.81M | $145.07M | $157.11M | $129.96M | $39.78M |
| Gross Profit | $69.73M | $67.29M | $58.12M | $60.88M | $13.85M |
| Gross Margin | 49.5% | 46.4% | 37.0% | 46.8% | 34.8% |
| Operating Income | $-61,302,038 | $-89,300,362 | $-192,748,615 | $-222,296,159 | $-96,603,464 |
| Net Income | $-165,554,955 | $-145,445,431 | $-475,749,370 | $-277,046,611 | $-112,264,844 |
| Net Margin | -117.6% | -100.3% | -302.8% | -213.2% | -282.2% |
| EPS | $-0.14 | $-0.27 | $-1.76 | $-2.62 | $-2.77 |
Company Overview
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the MedMen Red and LuxLyte brand names. As of December 25, 2021, it operated 29 stores in California, Florida, Nevada, Illinois, Arizona, Massachusetts, and New York. MedMen Enterprises Inc. is headquartered in Culver City, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MMNFFBeat Rate
14%
Last 14 quarters
Avg Surprise
-117.3%
EPS vs Estimate
Beats / Misses
2/10
2 met exactly
Latest EPS
$-0.02
Q3 2023
EPS Surprise History
Q3 21
-50.0%
$-0.06vs$-0.04
Q4 21
-500.0%
$-0.06vs$-0.01
Q1 22
-24.0%
$-0.01vs$-0.01
Q2 22
-61.9%
$-0.02vs$-0.01
Q3 22
-647.9%
$-0.07vs$-0.01
Q4 22
-55.6%
$-0.02vs$-0.01
Q1 23
+71.0%
$-0.01vs$-0.04
Q3 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 29, 2024 | — | — | — | — |
Q2 2024 | May 24, 2024 | $-0.04 | — | — | — |
Q1 2024 | Feb 12, 2024 | $-0.04 | — | — | — |
Q4 2023 | Nov 20, 2023 | $-0.04 | — | — | — |
Q3 2023 | Jul 3, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 26, 2023 | $-0.04 | — | — | — |
Q1 2023 | Feb 1, 2023 | $-0.04 | $-0.01 | +71.0% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $-0.01 | $-0.02 | -55.6% | ✗ MISS |
Q3 2022 | Sep 9, 2022 | $-0.01 | $-0.07 | -647.9% | ✗ MISS |
Q2 2022 | May 10, 2022 | $-0.01 | $-0.02 | -61.9% | ✗ MISS |
Q1 2022 | Feb 8, 2022 | $-0.01 | $-0.01 | -24.0% | ✗ MISS |
Q4 2021 | Nov 9, 2021 | $-0.01 | $-0.06 | -500.0% | ✗ MISS |
Q3 2021 | Sep 23, 2021 | $-0.04 | $-0.06 | -50.0% | ✗ MISS |
Q2 2021 | May 11, 2021 | $-0.02 | $-0.03 | -33.3% | ✗ MISS |
Q1 2021 | Feb 16, 2021 | $-0.11 | $-0.11 | 0.0% | = MET |
Q4 2020 | Dec 7, 2020 | $-0.07 | $-0.07 | 0.0% | = MET |
Q2 2020 | May 27, 2020 | $-0.05 | $-0.13 | -160.0% | ✗ MISS |
Q1 2020 | Feb 26, 2020 | $-0.08 | $-0.19 | -137.5% | ✗ MISS |
Q4 2019 | Nov 26, 2019 | $-0.10 | $-0.16 | -60.0% | ✗ MISS |
Q4 2019 | Oct 28, 2019 | $-0.12 | $-0.10 | +16.7% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about MMNFF
What is MMNFF's current stock price?
MedMen Enterprises Inc. (MMNFF) is currently trading at $0.00 per share. The stock has moved +9900.00% today.
What is the analyst price target for MMNFF?
No analyst price targets are currently available for this stock.
What sector is MedMen Enterprises Inc. in?
MedMen Enterprises Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is MMNFF's market cap?
MedMen Enterprises Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does MMNFF pay dividends?
No, MedMen Enterprises Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALEAF
Aleafia Health Inc.
$0.00
Mkt Cap: $0.0B
APTCF
Advanced Proteome Therapeutics Corporation
$0.00
Mkt Cap: $0.0B
EDNEF
Eden Empire Inc.
$0.00
Mkt Cap: $0.0B
ENDP
Endo International plc
$0.37
0MRVT
Miravant Medical Technologies Inc.
$0.00
Mkt Cap: $0.0B
POTN
PotNetwork Holdings, Inc.
$0.00
Mkt Cap: $0.0B
PRED
Predictive Technology Group, Inc.
$0.00
Mkt Cap: $0.0B
PVTTF
Pivotal Therapeutics Inc.
$0.00
Mkt Cap: $0.0B
QTXB
QuantRx Biomedical Corporation
$0.00
Mkt Cap: $0.0B
SNDD
RedHawk Holdings Corp.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to MMNFF for comparison